Targeting the MAPK Pathway in Cancer
Sultan F. Kadasah · 2025
Read Targeting the MAPK Pathway in Cancer by Sultan F. Kadasah (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12786225.txt.
Description
Sultan F Kadasah reviews the most targeted pathway in cancer drug design. His 2025 narrative review covers the MAPK signaling cascade, a relay that governs cell growth, division, and death, and whose breakage at any link can free cells to grow unchecked into tumors.
Drugs blocking the relay work, but cancers learn detours: parallel cascades that bypass the block, and reactivation downstream of it. The review catalogs counter-moves, from combination therapies and downstream targeting to degrader drugs that destroy pathway proteins outright. A newer thread links the pathway to ferroptosis, an iron-driven cell death, through several of its regulators. Kadasah stresses that future designs must reckon with crosstalk, compensation, and the tumor's neighborhood from the start.
Catalog record
| CREATOR | Sultan F. Kadasah |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |